Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Zyversa Therapeutics Inc (ZVSA)

Zyversa Therapeutics Inc (ZVSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
ZyVersa Therapeutics Announces Promising Findings for Inflammasome ASC Inhibitor IC 100 in Stroke-Related Cardiovascular Injury Quiver Quantitative, Inc. - Wed Nov 20, 5:04PM CST

ZyVersa announces data showing Inflammasome ASC Inhibitor IC 100 may improve cardiac function post-stroke related to obesity.Quiver AI SummaryZyVersa Therapeutics has announced promising new data regarding...

ZVSA : 1.1150 (-1.33%)
ZyVersa Therapeutics Announces Peer-Reviewed Publication Demonstrating That Inflammasome ASC Inhibitor IC 100 Protects Against Stroke-Related Cardiovascular Injury and Dysfunction in Preclinical Trial GlobeNewswire - Wed Nov 20, 6:55AM CST

ZVSA : 1.1150 (-1.33%)
ZyVersa Therapeutics Reports Third Quarter, 2024 Financial Results and Provides Business Update GlobeNewswire - Thu Nov 14, 7:10AM CST

ZVSA : 1.1150 (-1.33%)
ZyVersa Therapeutics Highlights Published Data Demonstrating the Potential of Inflammasome Inhibition to Protect Pancreatic Islet Beta Cells and Attenuate Progression from Obesity to Insulin Resistance and Type 2 Diabetes GlobeNewswire - Tue Nov 5, 6:00AM CST

ZVSA : 1.1150 (-1.33%)
ZyVersa Therapeutics Highlights Review Article Supporting the Need for Drug Therapies to Treat the Inflammation of Obesity in Addition to Weight Loss Drugs GlobeNewswire - Tue Oct 29, 6:57AM CDT

ZVSA : 1.1150 (-1.33%)
ZyVersa Therapeutics Highlights Published Data Demonstrating That Obesity Results in Neuroinflammation Implicated in Development of Neurodegenerative Diseases GlobeNewswire - Tue Oct 22, 6:57AM CDT

ZVSA : 1.1150 (-1.33%)
ZyVersa Therapeutics CEO, Stephen C. Glover, Issues Letter to Shareholders Highlighting Obesity Development Plans for Inflammasome ASC Inhibitor IC 100 Over the Next Nine Months GlobeNewswire - Thu Oct 17, 6:50AM CDT

ZVSA : 1.1150 (-1.33%)
ZyVersa Therapeutics CEO, Stephen C. Glover, Was a Featured Guest on The Big Biz Show to Discuss Current Trends in the Obesity Drug Market and the Potential Role of Inflammasome Inhibitors GlobeNewswire - Tue Oct 15, 6:50AM CDT

ZVSA : 1.1150 (-1.33%)
ZyVersa Therapeutics Forms New Scientific Advisory Board to Support Development of Inflammasome ASC Inhibitor IC 100 for Obesity with Metabolic Complications GlobeNewswire - Mon Oct 7, 6:55AM CDT

ZVSA : 1.1150 (-1.33%)
ZyVersa Therapeutics Appoints Three New Board Members PR Newswire - Thu Jan 5, 2023

/PRNewswire/ -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or "ZyVersa"), a clinical- stage specialty biopharmaceutical company developing first-in-class drugs...

ZVSA : 1.1150 (-1.33%)
FWBI : 2.96 (+4.59%)

Barchart Exclusives

Monolithic Power Stock: Buy, Sell, or Hold? Barchart - 1 hour ago
MPWR stock has slid more than 30% since its last earnings report. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot